1. Home
  2. ELVN vs SCSC Comparison

ELVN vs SCSC Comparison

Compare ELVN & SCSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELVN
  • SCSC
  • Stock Information
  • Founded
  • ELVN 2016
  • SCSC 1992
  • Country
  • ELVN United States
  • SCSC United States
  • Employees
  • ELVN N/A
  • SCSC N/A
  • Industry
  • ELVN Biotechnology: Pharmaceutical Preparations
  • SCSC Retail: Computer Software & Peripheral Equipment
  • Sector
  • ELVN Health Care
  • SCSC Technology
  • Exchange
  • ELVN Nasdaq
  • SCSC Nasdaq
  • Market Cap
  • ELVN 927.8M
  • SCSC 732.8M
  • IPO Year
  • ELVN 2020
  • SCSC 1994
  • Fundamental
  • Price
  • ELVN $20.64
  • SCSC $42.74
  • Analyst Decision
  • ELVN Strong Buy
  • SCSC Hold
  • Analyst Count
  • ELVN 5
  • SCSC 1
  • Target Price
  • ELVN $41.20
  • SCSC N/A
  • AVG Volume (30 Days)
  • ELVN 750.0K
  • SCSC 195.7K
  • Earning Date
  • ELVN 08-12-2025
  • SCSC 08-26-2025
  • Dividend Yield
  • ELVN N/A
  • SCSC N/A
  • EPS Growth
  • ELVN N/A
  • SCSC N/A
  • EPS
  • ELVN N/A
  • SCSC 2.78
  • Revenue
  • ELVN N/A
  • SCSC $2,974,037,000.00
  • Revenue This Year
  • ELVN N/A
  • SCSC N/A
  • Revenue Next Year
  • ELVN N/A
  • SCSC $4.96
  • P/E Ratio
  • ELVN N/A
  • SCSC $15.30
  • Revenue Growth
  • ELVN N/A
  • SCSC N/A
  • 52 Week Low
  • ELVN $13.30
  • SCSC $28.75
  • 52 Week High
  • ELVN $30.03
  • SCSC $53.90
  • Technical
  • Relative Strength Index (RSI)
  • ELVN 51.64
  • SCSC 67.21
  • Support Level
  • ELVN $19.22
  • SCSC $41.42
  • Resistance Level
  • ELVN $21.90
  • SCSC $42.37
  • Average True Range (ATR)
  • ELVN 1.49
  • SCSC 1.04
  • MACD
  • ELVN -0.22
  • SCSC -0.01
  • Stochastic Oscillator
  • ELVN 37.81
  • SCSC 82.37

About ELVN Enliven Therapeutics Inc.

Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.

About SCSC ScanSource Inc.

ScanSource Inc provides value-added services for technology manufacturers and sells to resellers in specialty technology markets. The firm's operations are organized in two segments: Specialty Technology Solutions and Modern Communications and Cloud. It generates maximum revenue from the Specialty Technology Solutions segment. The Specialty Technology Solutions segment includes the company's business in mobility and barcode, POS, payments, security and networking technologies. Geographically, it derives a majority of revenue from the United States.

Share on Social Networks: